Rejean L Idzerda

Title: Rejean L Idzerda: Innovator in Cancer Research

Introduction

Rejean L Idzerda is a prominent inventor based in Seattle, WA, known for his significant contributions to cancer research. With a focus on therapeutic methods using antibodies, he has made strides in understanding and treating various forms of cancer. His work has led to the development of several patents that enhance the field of immunotherapy.

Latest Patents

Idzerda holds 5 patents, with his latest innovations including methods of using CD44-specific antibodies. These patents focus on therapeutic methods using antibodies to an adhesion receptor for high endothelial venules (HEV). Additionally, he has developed fragments of a lymphocyte adhesion receptor for high endothelium, specifically CD44, which includes a lymphoid cell line cDNA that encodes an adhesion receptor for high endothelial venules (HEV).

Career Highlights

Rejean L Idzerda is affiliated with the Fred Hutchinson Cancer Center, where he conducts his research and development. His work at this esteemed institution has positioned him as a key player in the field of cancer immunotherapy.

Collaborations

Throughout his career, Idzerda has collaborated with notable colleagues, including Thomas P St John and W Michael Gallatin. These partnerships have furthered his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Rejean L Idzerda's innovative work and patents in cancer research highlight his dedication to improving therapeutic methods. His contributions continue to impact the field significantly, paving the way for future advancements in cancer treatment.